Tremblay D - Search Results

1

Clinical Benefit Derived from Decitabine Therapy for Advanced Phases of Myeloproliferative Neoplasms.

Zhou S, Tremblay D, Hoffman R, Kremyanskaya M, Najfeld V, Li L, Moshier E, Mascarenhas J. Zhou S, et al. Among authors: tremblay d. Acta Haematol. 2021;144(1):48-57. doi: 10.1159/000506146. Epub 2020 Mar 11. Acta Haematol. 2021. PMID: 32160610 Free PMC article.

2

Systemic Mastocytosis: Clinical Update and Future Directions.

Tremblay D, Carreau N, Kremyanskaya M, Mascarenhas J. Tremblay D, et al. Clin Lymphoma Myeloma Leuk. 2015 Dec;15(12):728-38. doi: 10.1016/j.clml.2015.07.644. Epub 2015 Aug 5. Clin Lymphoma Myeloma Leuk. 2015. PMID: 26382091 Review.

3

Ironing out the details of iron overload in myelofibrosis: Lessons from myelodysplastic syndromes.

Carreau N, Tremblay D, Savona M, Kremyanskaya M, Mascarenhas J. Carreau N, et al. Among authors: tremblay d. Blood Rev. 2016 Sep;30(5):349-56. doi: 10.1016/j.blre.2016.04.003. Epub 2016 Apr 20. Blood Rev. 2016. PMID: 27106071 Review.

4

Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies.

Zahr AA, Salama ME, Carreau N, Tremblay D, Verstovsek S, Mesa R, Hoffman R, Mascarenhas J. Zahr AA, et al. Among authors: tremblay d. Haematologica. 2016 Jun;101(6):660-71. doi: 10.3324/haematol.2015.141283. Haematologica. 2016. PMID: 27252511 Free PMC article. Review.

5

Discontinuing Tyrosine Kinase Inhibitor Therapy in Chronic Myelogenous Leukemia: Current Understanding and Future Directions.

Bhalla S, Tremblay D, Mascarenhas J. Bhalla S, et al. Among authors: tremblay d. Clin Lymphoma Myeloma Leuk. 2016 Sep;16(9):488-494. doi: 10.1016/j.clml.2016.06.012. Epub 2016 Jun 16. Clin Lymphoma Myeloma Leuk. 2016. PMID: 27406834 Review.

6

Programmed cell death-1 pathway inhibition in myeloid malignancies: implications for myeloproliferative neoplasms.

Choi DC, Tremblay D, Iancu-Rubin C, Mascarenhas J. Choi DC, et al. Among authors: tremblay d. Ann Hematol. 2017 Jun;96(6):919-927. doi: 10.1007/s00277-016-2915-4. Epub 2017 Jan 6. Ann Hematol. 2017. PMID: 28062906 Review.

7

Outcomes of salvage autologous stem cell transplantation for multiple myeloma with cytopenias and exposure to novel agents.

Tremblay D, Lancman G, Moshier E, Bar N, Jagannath S, Chari A. Tremblay D, et al. Bone Marrow Transplant. 2017 Oct;52(10):1468-1470. doi: 10.1038/bmt.2017.160. Epub 2017 Jul 24. Bone Marrow Transplant. 2017. PMID: 28737774 No abstract available.

8

Pharmacotherapy of Myelofibrosis.

Tremblay D, Marcellino B, Mascarenhas J. Tremblay D, et al. Drugs. 2017 Sep;77(14):1549-1563. doi: 10.1007/s40265-017-0797-y. Drugs. 2017. PMID: 28791654 Review.

9

Reassessing the safety concerns of utilizing blood donations from patients with hemochromatosis.

Winters AC, Tremblay D, Arinsburg S, Mascarenhas J, Schiano TD. Winters AC, et al. Among authors: tremblay d. Hepatology. 2018 Mar;67(3):1150-1157. doi: 10.1002/hep.29521. Epub 2018 Jan 31. Hepatology. 2018. PMID: 28902419 Review.

10

The effect of novel therapies in high-molecular-risk multiple myeloma.

Lancman G, Tremblay D, Barley K, Barlogie B, Cho HJ, Jagannath S, Madduri D, Moshier E, Parekh S, Chari A. Lancman G, et al. Among authors: tremblay d. Clin Adv Hematol Oncol. 2017 Nov;15(11):870-879. Clin Adv Hematol Oncol. 2017. PMID: 29200420 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

391 results

Search Page

Filters